Martin Friede

New horizons in adjuvants for vaccine development

Steven G. Reed, Sylvie Bertholet, Rhea N. Coler et al. · Trends in Immunology · 2008 · 611 citations

Vaccinology, Vaccination, Vaccine Development +4

Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant

Rhea N. Coler, Sylvie Bertholet, Magdalini Moutaftsi et al. · PLoS ONE · 2011 · 310 citations · Full text

Intradermal delivery of vaccines: potential benefits and current challenges

J F Hickling, K.F Jones, Martin Friede et al. · Bulletin of the World Health Organization · 2011 · 186 citations · Full text

Vaccination, Vaccinology, Cross-protection +14

The Efficacy and Safety of <i>Tanacetum Parthenium</i> (Feverfew) in Migraine Prophylaxis—a Double-Blind, Multicentre, Randomized Placebo-Controlled Dose-Response Study

V. Pfaffenrath, HC Diener, Michael B. Fischer et al. · Cephalalgia · 2002 · 177 citations

Randomized Controlled Clinical Trial of Fractional Doses of Inactivated Poliovirus Vaccine Administered Intradermally by Needle‐Free Device in Cuba

Sonia Resik, Alina Tejeda, Pedro Más Lago et al. · The Journal of Infectious Diseases · 2010 · 146 citations